NCT03266393View on ClinicalTrials.gov

Envarsus XR® in Adolescent Renal Transplant Recipients

PHASE4Active, not recruitingINTERVENTIONAL

Enrollment

28

Participants

Timeline

Start Date

January 15, 2019

Primary Completion Date

March 31, 2023

Study Completion Date

March 31, 2023

Conditions

Kidney TransplantationRenal TransplantationGrafting, Kidney

Interventions

DRUG

Envarsus XR

Once daily sustained-release tacrolimus

DRUG

Tacrolimus

Twice daily immediate-release tacrolimus

Trial Locations (1)

90095

UCLA Transplantation Services, Los Angeles

Sponsors

Collaborators (1)

Veloxis Pharmaceuticals

All Listed Sponsors

collaborator

Veloxis Pharmaceuticals

INDUSTRY

lead

University of California, Los Angeles

OTHER

NCT03266393 - Envarsus XR® in Adolescent Renal Transplant Recipients | Biotech Hunter | Biotech Hunter